IntrinsicIntrinsic
← All summaries

NATIONAL HEALTHCARE CORP

NHC
Financials & Chart →

Business Summary

National HealthCare Corporation (NHC) operates in the post-acute and senior healthcare services industry, providing skilled nursing, assisted living, independent living, behavioral health, homecare, and hospice services. The company operates in 9 states , primarily in the Southeastern and Midwestern United States. The industry is characterized by extensive regulatory oversight from federal and state agencies, including licensure, certification, and reimbursement rules under Medicare and Medicaid. Key structural forces include the shift toward value-based purchasing, the Patient-Driven Payment Model (PDPM) for skilled nursing, and the Patient-Driven Groupings Model (PDGM) for homecare, which tie reimbursement to patient condition and quality outcomes rather than volume of services. The Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System is a key competitive benchmark, and the industry faces ongoing labor shortages and inflationary pressures on operating costs.

NHC competes with hundreds of operators of post-acute healthcare services across its operating states, with no single operator dominating any market except for some small rural markets with limited competition . The company differentiates itself through a continuum of care that links skilled nursing facilities with senior living communities, home health, hospice, and behavioral health hospitals, aiming to obtain a competitive advantage . As of December 31, 2025, NHC's skilled nursing facilities achieved an average Five-Star Quality Rating of 3.83 versus the industry average of 2.95 , with 62.5% of its 80 skilled nursing facilities rated 4 or 5 stars compared to 38.6% industry-wide. Competitors include not-for-profit, non-taxpaying, and governmental agencies that can finance capital expenditures on a tax-exempt basis and receive charitable contributions unavailable to NHC .

NHC generates revenue primarily through the operation of healthcare facilities and the provision of management, accounting, financial, and insurance services. In fiscal year 2025, 96.8% of net operating revenues were derived from healthcare services (net patient revenues), while 3.2% came from other sources including management fees, rental income, and insurance services. The company operates under a model that includes owned, leased, and managed facilities: as of December 31, 2025, NHC owned 43 skilled nursing facilities, leased 29 , and managed 8 ; owned 19 assisted living facilities, leased 5 , and managed 2 ; and owned 5 independent living facilities, leased 3 , and managed 1 . Recurring income streams include daily patient care payments from Medicare, Medicaid, managed care, and private pay sources, as well as management fees typically charged at 6% of managed centers' net operating revenues. The company also operates an Institutional Special Needs Plan (I-SNP) called NHC Advantage, a managed care insurance company that receives a per member, per month premium from Medicare .

NHC's inpatient services segment includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and behavioral health hospitals. As of December 31, 2025, the company operated or managed 80 skilled nursing facilities with 10,329 licensed beds, 26 assisted living facilities with 1,413 units, 9 independent living facilities with 777 retirement apartments, and 3 behavioral health hospitals with 102 licensed beds. For the year ended December 31, 2025, inpatient services generated net patient revenues of $1,315,545,000 and other revenues of $1,467,000 , for total net operating revenues of $1,317,012,000 . The segment reported income from operations of $127,751,000 for 2025. Occupancy rates for owned and leased skilled nursing facilities were 89.7% in 2025, compared to 88.6% in 2024 and 87.9% in 2023. Assisted living occupancy was 84.3% in 2025 versus 81.1% in 2024, and independent living occupancy was 93.8% in 2025 versus 93.2% in 2024. The segment also includes rehabilitative services with a rehabilitation staff of over 1,230 therapists, medical specialty units including memory care and sub-acute nursing units, and pharmacy operations with five regional pharmacy locations .

NHC's homecare and hospice services segment includes 34 homecare agencies and 33 hospice agencies operating under the Caris Healthcare brand. For the year ended December 31, 2025, this segment generated net patient revenues of $154,086,000 and reported income from operations of $30,060,000 . In 2025, homecare agencies served an average census of 3,834 patients and provided 339,344 visits. Hospice services, provided through Caris Healthcare, cared for over 1,647 patients per day across 33 locations in Georgia, Missouri, South Carolina, Tennessee, and Virginia. The I-SNP, NHC Advantage, operated in Tennessee, Missouri, and South Carolina with approximately 1,300 members enrolled as of December 31, 2025. Other revenue sources include management, accounting, and financial services provided to 11 healthcare facilities for management and 14 healthcare facilities for accounting and financial services as of December 31, 2025, rental income from 10 healthcare properties leased to third-party operators, and insurance services through two wholly-owned insurance subsidiaries providing workers' compensation and professional liability coverage.

On August 1, 2024, the Company purchased the assets of White Oak Management, Inc., a portfolio consisting of 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy, with 1,928 licensed skilled nursing beds, 48 assisted living units, and 302 independent living units in South Carolina and North Carolina. During 2025, the Company purchased 127,338 shares of its common stock for a total cost of $14,730,000 . The Company also contributed land to a newly-formed limited liability company resulting in an equity interest; the fair value of the land contributed was $5,625,000 with a cost basis of $2,019,000 , generating a gain of $3,606,000 netted within other operating expenses. Dividends declared per common share were $2.53 in 2025, compared to $2.42 in 2024 and $2.34 in 2023. The Company recorded $9,445,000 of government stimulus income related to the Employee Retention Credit in 2024. On July 29, 2025, NHI notified NHC of alleged non-compliance with certain non-monetary provisions of the Master Lease, and on September 8, 2025, NHI formally alleged a default; NHC disputes that any default has occurred .

For the fiscal year ended December 31, 2025, NHC reported total net operating revenues and stimulus income of $1,517,781,000 , an increase of 16.1% compared to $1,307,382,000 in 2024. Net income attributable to NHC was $120,015,000 in 2025, compared to $101,927,000 in 2024 and $66,798,000 in 2023. Diluted earnings per share were $7.67 in 2025, versus $6.53 in 2024 and $4.34 in 2023. Income from operations was $128,352,000 in 2025, compared to $89,895,000 in 2024 and $57,458,000 in 2023. The overall average census in owned and leased skilled nursing facilities improved to 89.7% in 2025 from 88.6% in 2024. The composite skilled nursing facility per diem increased 4.0% in 2025 compared to 2024. Cash provided by operating activities was $185,078,000 in 2025, compared to $107,303,000 in 2024.

Business Outlook

A primary growth vector is the expansion of post-acute and senior healthcare operations through construction and acquisitions. Recent activities include the August 1, 2024 acquisition of the White Oak portfolio, which added 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy with 1,928 licensed skilled nursing beds, 48 assisted living units, and 302 independent living units in South Carolina and North Carolina. The company also opened new hospice agencies in Morristown, TN (April 2024), Lawrenceburg, TN (July 2024), Wytheville, VA (August 2024), and Clinton, TN (October 2024) . In 2023, NHC opened new assisted living facilities in Vero Beach, FL (135 units ), Merritt Island, FL (95 units ), and Stuart, FL (100 units ), and acquired a skilled nursing facility with 66 beds in Nashville, TN. The company is also investing in joint venture multi-family developments under construction in Nashville, Tennessee, contributing capital of $5,629,000 in 2025.

Another growth vector is the expansion of the I-SNP, NHC Advantage, which restricts enrollment to Medicare Advantage eligible individuals who have had or are expected to need skilled nursing facility level of services for 90 days or longer . As of December 31, 2025, the I-SNP operated in Tennessee, Missouri, and South Carolina with approximately 1,300 members. The company believes the I-SNP benefits patients by providing nurse practitioners and care-coordination teams that enhance the patient-centered experience and quality of care . Additionally, NHC is in various stages of partnerships with hospital systems, payors, and other post-acute alliances to better position itself as an active participant in the delivery of post-acute healthcare services .

Management focuses on margin trajectory through labor cost control and operational efficiency. Salaries, wages, and benefits as a percentage of net operating revenues and stimulus income improved to 60.7% in 2025 from 62.0% in 2024. Agency nurse staffing expenses decreased $9,335,000 , or approximately 66.6% , in 2025 compared to 2024, and decreased $19,962,000 , or approximately 66.2% , in 2024 compared to 2023. Total costs and expenses as a percentage of net operating revenues and stimulus income improved to 91.6% in 2025 from 93.1% in 2024 and 94.9% in 2023. Income from operations as a percentage of net operating revenues and stimulus income improved to 8.4% in 2025 from 6.9% in 2024 and 5.1% in 2023. The company faces inflationary pressures in certain categories within other operating expenses, such as food/dietary supplies and drugs/pharmaceutical supplies .

The company is undertaking a process to allocate more aggressive capital spending within its owned and leased facilities to address issues arising from an aging physical plant . As of December 31, 2025, NHC leased or owned 72 skilled nursing facilities, 24 assisted living facilities, three behavioral health hospitals, and eight independent living facilities. The company continues to refine and implement information technology to improve customer service, enhance operating efficiencies, and provide more effective management of business operations . NHC had 15,278 full-time and part-time employees as of December 31, 2025, and faces competition in employing and retaining nurses, technicians, aides, and other high-quality professional and non-professional employees .

Capital allocation priorities include investing in property and equipment, share repurchases, and dividend payments. Cash used for property and equipment additions was $36,446,000 in 2025, $27,600,000 in 2024, and $27,901,000 in 2023. In 2025, the Company purchased 127,338 shares of its common stock for $14,730,000 . The Company has paid a common dividend since 2004 , with dividends declared per common share of $2.53 in 2025, $2.42 in 2024, and $2.34 in 2023. Dividends paid to common stockholders were $38,704,000 in 2025, $36,964,000 in 2024, and $35,560,000 in 2023. The Company has a $50 million available line of credit and had borrowing capacity on that facility as of December 31, 2025. The Company also has unencumbered real estate assets that could potentially be used as collateral in future borrowing opportunities .

A significant headwind is the dispute with National Health Investors, Inc. (NHI) regarding the Master Lease covering a significant portion of NHC's skilled nursing and independent living facilities. On July 29, 2025, NHI notified NHC of alleged non-compliance with certain non-monetary provisions, and on September 8, 2025, NHI formally alleged a default based on four non-monetary provisions . NHC disputes that any default has occurred and continues to communicate with NHI to resolve these matters . In October 2025, NHC provided NHI with notice of intent to exercise its right to extend the Master Lease for an additional five-year term beginning January 1, 2027 . Failure to resolve the disputes or secure renewal on acceptable terms could result in loss of the right to occupy and operate some or all affected facilities, or subject NHC to damages, acceleration of rent, or other remedies .

Structural headwinds include the ongoing healthcare labor shortage, which has amplified the challenge of maintaining desirable patient census levels . The company faces competition in employing and retaining qualified personnel, especially facility administrators, nurses, certified nurses' aides, and other important healthcare providers . The difficulty in hiring and retaining qualified personnel has increased average wage rates . Additionally, certain states have adopted minimum staffing standards, and failure to comply may result in fines or other sanctions . The company also faces uncertainty regarding Medicare and Medicaid reimbursement rates, with the Budget Control Act of 2011 imposing Medicare spending reductions of up to 2% per fiscal year, extended through 2030 . CMS projects payments to home health agencies in fiscal year 2026 will decrease by 1.3% or $220 million relative to the prior year.

Risk Factors

NHC derives a substantial portion of revenue from Medicare and Medicaid, and changes in reimbursement rates or methods could materially reduce revenues and operating margins. The Budget Control Act of 2011 imposes Medicare spending reductions of up to 2% per fiscal year, extended through 2030 . CMS projects a 1.3% decrease, or $220 million , in home health payments for fiscal year 2026. The dispute with NHI over the Master Lease creates significant uncertainty; NHI formally alleged a default based on four non-monetary provisions on September 8, 2025 , and failure to resolve could result in loss of the right to occupy and operate some or all affected facilities . The company is largely self-insured for professional liability and workers' compensation, with accrued risk reserves totaling $121,595,000 at December 31, 2025. Unfavorable claims activity resulted in additional other operating expenses of $17,563,000 in 2025 compared to 2024. The company faces a highly competitive labor market with a shortage of nurses and other key personnel, which has increased average wage rates and resulted in agency nurse staffing expenses, though these decreased by $9,335,000 or 66.6% in 2025. The investment portfolio is concentrated in NHI common stock, which comprised $124,532,000 , or 69.1% , of the total fair value of marketable equity securities at December 31, 2025, creating concentration risk.

Management Priorities

Management's tone in the filing is focused on operational improvement, quality of care, and strategic growth. Key themes include the continued increase in skilled nursing census, per diem increases from governmental payors, the reduction of agency staffing expense, and the accretive contribution of the White Oak acquisition. Management emphasizes that the company has always strived for patient-centered care and quality outcomes as precursors to outstanding financial performance . Specific forward-looking statements include the estimate that the Tennessee Medicaid increase effective July 1, 2025 will result in approximately $3,000,000 annually, or $750,000 per quarter, and the South Carolina Medicaid increase effective October 1, 2025 will result in approximately $4,200,000 annually, or $1,050,000 per quarter. Management also notes that the fiscal year 2026 CMS rule for skilled nursing facilities equates to a net 3.2% increase in Medicare Part A payments, and the hospice payment update includes a 2.6% rate increase, or $750 million . Strategic priorities emphasized include expanding post-acute and senior healthcare operations while protecting existing operations and markets, linking skilled nursing facilities with senior living communities, home health, hospice, and behavioral health hospitals to obtain a competitive advantage , and working internally to improve systems to be most responsive to referral sources and payors while finding creative initiatives to retain and attract qualified healthcare professionals .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 1, Business — Description of the Business
  2. [2] Item 1, Business — Competition
  3. [3] Item 1, Business — Competition
  4. [4] Item 1, Business — Quality of Patient Care
  5. [5] Item 1, Business — Quality of Patient Care
  6. [6] Item 1, Business — Quality of Patient Care
  7. [7] Item 1, Business — Description of the Business
  8. [8] Item 1, Business — Quality of Patient Care
  9. [9] Item 1A, Risk Factors — If we fail to compete effectively
  10. [10] Item 7, MD&A — Results of Operations
  11. [11] Item 1, Business — Other Revenues
  12. [12] Item 1, Business — Description of the Business
  13. [13] Item 1, Business — Description of the Business
  14. [14] Item 1, Business — Description of the Business
  15. [15] Item 1, Business — Description of the Business
  16. [16] Item 1, Business — Description of the Business
  17. [17] Item 1, Business — Description of the Business
  18. [18] Item 1, Business — Description of the Business
  19. [19] Item 1, Business — Description of the Business
  20. [20] Item 1, Business — Description of the Business
  21. [21] Item 1, Business — Net Patient Revenues
  22. [22] Item 1, Business — Institutional Special Needs Plan
  23. [23] Item 1, Business — Description of the Business
  24. [24] Item 1, Business — Description of the Business
  25. [25] Item 1, Business — Description of the Business
  26. [26] Item 1, Business — Description of the Business
  27. [27] Item 1, Business — Description of the Business
  28. [28] Item 1, Business — Description of the Business
  29. [29] Item 1, Business — Description of the Business
  30. [30] Item 1, Business — Description of the Business
  31. [31] Item 7, MD&A — Segment Reporting
  32. [32] Item 7, MD&A — Segment Reporting
  33. [33] Item 7, MD&A — Segment Reporting
  34. [34] Item 7, MD&A — Segment Reporting
  35. [35] Item 7, MD&A — Executive Summary
  36. [36] Item 7, MD&A — Executive Summary
  37. [37] Item 7, MD&A — Executive Summary
  38. [38] Item 1, Business — Assisted Living Facilities
  39. [39] Item 1, Business — Assisted Living Facilities
  40. [40] Item 1, Business — Independent Living Facilities
  41. [41] Item 1, Business — Independent Living Facilities
  42. [42] Item 1, Business — Rehabilitative Services
  43. [43] Item 1, Business — Pharmacy Operations
  44. [44] Item 1, Business — Description of the Business
  45. [45] Item 1, Business — Description of the Business
  46. [46] Item 7, MD&A — Segment Reporting
  47. [47] Item 7, MD&A — Segment Reporting
  48. [48] Item 1, Business — Homecare Agencies
  49. [49] Item 1, Business — Homecare Agencies
  50. [50] Item 1, Business — Hospice Agencies
  51. [51] Item 1, Business — Hospice Agencies
  52. [52] Item 1, Business — Institutional Special Needs Plan
  53. [53] Item 1, Business — Management, Accounting and Financial Services
  54. [54] Item 1, Business — Management, Accounting and Financial Services
  55. [55] Item 1, Business — Rental Income
  56. [56] Item 1, Business — Development and Growth
  57. [57] Item 1, Business — Development and Growth
  58. [58] Item 1, Business — Development and Growth
  59. [59] Item 1, Business — Development and Growth
  60. [60] Item 1, Business — Development and Growth
  61. [61] Item 1, Business — Development and Growth
  62. [62] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
  63. [63] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
  64. [64] Item 7, MD&A — 2025 Compared to 2024
  65. [65] Item 7, MD&A — 2025 Compared to 2024
  66. [66] Item 7, MD&A — 2025 Compared to 2024
  67. [67] Item 8, Financial Statements — Consolidated Statements of Operations
  68. [68] Item 8, Financial Statements — Consolidated Statements of Operations
  69. [69] Item 8, Financial Statements — Consolidated Statements of Operations
  70. [70] Item 1, Business — Government Stimulus Income
  71. [71] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  72. [72] Item 8, Financial Statements — Consolidated Statements of Operations
  73. [73] Item 7, MD&A — 2025 Compared to 2024
  74. [74] Item 8, Financial Statements — Consolidated Statements of Operations
  75. [75] Item 8, Financial Statements — Consolidated Statements of Operations
  76. [76] Item 8, Financial Statements — Consolidated Statements of Operations
  77. [77] Item 8, Financial Statements — Consolidated Statements of Operations
  78. [78] Item 8, Financial Statements — Consolidated Statements of Operations
  79. [79] Item 8, Financial Statements — Consolidated Statements of Operations
  80. [80] Item 8, Financial Statements — Consolidated Statements of Operations
  81. [81] Item 8, Financial Statements — Consolidated Statements of Operations
  82. [82] Item 8, Financial Statements — Consolidated Statements of Operations
  83. [83] Item 8, Financial Statements — Consolidated Statements of Operations
  84. [84] Item 7, MD&A — Executive Summary
  85. [85] Item 7, MD&A — Executive Summary
  86. [86] Item 7, MD&A — 2025 Compared to 2024
  87. [87] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  88. [88] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  89. [89] Item 1, Business — Development and Growth
  90. [90] Item 1, Business — Development and Growth
  91. [91] Item 1, Business — Development and Growth
  92. [92] Item 1, Business — Development and Growth
  93. [93] Item 1, Business — Development and Growth
  94. [94] Item 1, Business — Development and Growth
  95. [95] Item 1, Business — Development and Growth
  96. [96] Item 1, Business — Development and Growth
  97. [97] Item 1, Business — Development and Growth
  98. [98] Item 1, Business — Development and Growth
  99. [99] Item 1, Business — Development and Growth
  100. [100] Item 7, MD&A — Investing Activities
  101. [101] Item 1, Business — Institutional Special Needs Plan
  102. [102] Item 1, Business — Institutional Special Needs Plan
  103. [103] Item 1, Business — Institutional Special Needs Plan
  104. [104] Item 7, MD&A — Executive Summary
  105. [105] Item 7, MD&A — Results of Operations
  106. [106] Item 7, MD&A — Results of Operations
  107. [107] Item 7, MD&A — 2025 Compared to 2024
  108. [108] Item 7, MD&A — 2025 Compared to 2024
  109. [109] Item 7, MD&A — 2024 Compared to 2023
  110. [110] Item 7, MD&A — 2024 Compared to 2023
  111. [111] Item 7, MD&A — Results of Operations
  112. [112] Item 7, MD&A — Results of Operations
  113. [113] Item 7, MD&A — Results of Operations
  114. [114] Item 7, MD&A — Results of Operations
  115. [115] Item 7, MD&A — Results of Operations
  116. [116] Item 7, MD&A — Results of Operations
  117. [117] Item 7, MD&A — 2024 Compared to 2023
  118. [118] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
  119. [119] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
  120. [120] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
  121. [121] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
  122. [122] Item 1A, Risk Factors — Upkeep of healthcare properties is capital intensive
  123. [123] Item 1A, Risk Factors — Implementation of new information technology
  124. [124] Item 1, Business — Human Capital
  125. [125] Item 1, Business — Human Capital
  126. [126] Item 7, MD&A — Investing Activities
  127. [127] Item 7, MD&A — Investing Activities
  128. [128] Item 7, MD&A — Investing Activities
  129. [129] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
  130. [130] Item 5, Market for Registrant's Common Equity — Stock Repurchase Programs
  131. [131] Item 5, Market for Registrant's Common Equity — Dividend Policy
  132. [132] Item 8, Financial Statements — Consolidated Statements of Operations
  133. [133] Item 8, Financial Statements — Consolidated Statements of Operations
  134. [134] Item 8, Financial Statements — Consolidated Statements of Operations
  135. [135] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  136. [136] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  137. [137] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  138. [138] Item 7, MD&A — Short-term liquidity
  139. [139] Item 7, MD&A — Long-term liquidity
  140. [140] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  141. [141] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  142. [142] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  143. [143] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  144. [144] Item 7, MD&A — Executive Summary
  145. [145] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
  146. [146] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
  147. [147] Item 1A, Risk Factors — The cost to replace or retain qualified nurses
  148. [148] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
  149. [149] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
  150. [150] Item 1, Business — Homecares
  151. [151] Item 1, Business — Homecares
  152. [152] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
  153. [153] Item 1A, Risk Factors — We depend on reimbursement from Medicare, Medicaid and other third-party payors
  154. [154] Item 1, Business — Homecares
  155. [155] Item 1, Business — Homecares
  156. [156] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  157. [157] Item 1A, Risk Factors — The status of our lease with National Health Investors, Inc.
  158. [158] Item 7, MD&A — Accrued Risk Reserves
  159. [159] Item 7, MD&A — 2025 Compared to 2024
  160. [160] Item 7, MD&A — 2025 Compared to 2024
  161. [161] Item 7, MD&A — 2025 Compared to 2024
  162. [162] Item 7A, Quantitative and Qualitative Disclosure About Market Risk
  163. [163] Item 7A, Quantitative and Qualitative Disclosure About Market Risk
  164. [164] Item 1, Business — Quality of Patient Care
  165. [165] Item 1, Business — Medicaid Legislation and Regulations
  166. [166] Item 1, Business — Medicaid Legislation and Regulations
  167. [167] Item 1, Business — Medicaid Legislation and Regulations
  168. [168] Item 1, Business — Medicaid Legislation and Regulations
  169. [169] Item 1, Business — Medicare Legislation and Regulations
  170. [170] Item 1, Business — Hospice
  171. [171] Item 1, Business — Hospice
  172. [172] Item 1, Business — Competition
  173. [173] Item 7, MD&A — Executive Summary
  174. [174] Item 8, Financial Statements — Consolidated Statements of Operations
  175. [175] Item 8, Financial Statements — Consolidated Statements of Operations
  176. [176] Item 8, Financial Statements — Consolidated Statements of Operations
  177. [177] Item 8, Financial Statements — Consolidated Statements of Operations
  178. [178] Item 8, Financial Statements — Consolidated Statements of Operations
  179. [179] Item 8, Financial Statements — Consolidated Statements of Operations
  180. [180] Item 8, Financial Statements — Consolidated Statements of Operations
  181. [181] Item 8, Financial Statements — Consolidated Statements of Operations
  182. [182] Item 8, Financial Statements — Consolidated Statements of Operations
  183. [183] Item 8, Financial Statements — Consolidated Statements of Operations
  184. [184] Item 8, Financial Statements — Consolidated Statements of Operations
  185. [185] Item 8, Financial Statements — Consolidated Statements of Operations
  186. [186] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  187. [187] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  188. [188] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  189. [189] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  190. [190] Item 8, Financial Statements — Consolidated Statements of Cash Flows
  191. [191] Item 8, Financial Statements — Consolidated Balance Sheets
  192. [192] Item 8, Financial Statements — Consolidated Balance Sheets
  193. [193] Item 8, Financial Statements — Consolidated Balance Sheets
  194. [194] Item 8, Financial Statements — Consolidated Balance Sheets
  195. [195] Item 8, Financial Statements — Consolidated Balance Sheets
  196. [196] Item 8, Financial Statements — Consolidated Balance Sheets
  197. [197] Item 8, Financial Statements — Consolidated Statements of Operations
  198. [198] Item 7, MD&A — 2025 Compared to 2024
  199. [199] Item 8, Financial Statements — Consolidated Statements of Operations
  200. [200] Item 7, MD&A — 2024 Compared to 2023
  201. [201] Item 8, Financial Statements — Consolidated Statements of Operations
  202. [202] Item 8, Financial Statements — Consolidated Statements of Operations
  203. [203] Item 7, MD&A — 2025 Compared to 2024
  204. [204] Item 1, Business — Government Stimulus Income
  205. [205] Item 8, Financial Statements — Consolidated Statements of Operations
  206. [206] Item 7, MD&A — Segment Reporting
  207. [207] Item 7, MD&A — Segment Reporting
  208. [208] Item 7, MD&A — Segment Reporting
  209. [209] Item 7, MD&A — Segment Reporting

Analysis on 6/9/2026